Acus Laboratories

Curated by Signal

Developer of a platform for genetic screening for drug target analysis

Overview

Acus Laboratories has developed a genetic screening technology. The company uses technology that uses a combination of chemical mutagenesis, next-generation sequencing, and bioinformatics algorithms to identify specific amino acid on- and off-target space of drug candidates.

Key facts

Founded: 2018
Headquarters: Cologne, Germany
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

BAhead
Provider of AI-based lab automation and digitization solutions
Life Sciences TechnologyHamburg, Germany
Dytrex
Develops and markets hometesting diagnostic products
Life Sciences TechnologyBerlin, Germany
Localite
Developer of surgical navigation and planning systems
Life Sciences TechnologyBonn, Germany

About Acus Laboratories

What does Acus Laboratories do?

Acus Laboratories has developed a genetic screening technology.

Where is Acus Laboratories headquartered?

Acus Laboratories is headquartered in Cologne, Germany.

When was Acus Laboratories founded?

Acus Laboratories was founded in 2018.

Which sector is Acus Laboratories in?

Acus Laboratories operates in Life Sciences Technology.

Who are Acus Laboratories's competitors?

Companies similar to Acus Laboratories include BAhead, Dytrex, and Localite.